The Trump administration altered its stance and reinstated financial backing for long-standing studies focused on women’s health.
The National Institutes of Health (NIH) initiated the Women’s Health Initiative (WHI) in the early 1990s to address women’s health needs, as much medical research predominantly focused on men.
This week, WHI researchers were informed that contracts with four regional centers in California, New York, Ohio, and North Carolina would be terminated in September.
Funding for the initiative was initially cut by the Trump administration because the National Institutes of Health “had exceeded its internal contract reduction goals.” I informed NPR.
This month, the White House directed HHS to reduce contract expenditures by 35% and to use funds more effectively.
The decision rapidly alerted the scientific community, prompting many to advocate for a reversal of that decision.
“If a $10 million annual program can save an estimated $35.2 billion in healthcare costs while enhancing healthcare and life for postmenopausal women, it is not for nothing,” stated New York Sen. Nicole Mariotaki. On Social Platform X.
“This decision must be reconsidered, and a more careful and deliberate strategy for identifying savings should be employed,” she added.
Research from this initiative has led to improved treatments for conditions such as breast cancer and cardiovascular diseases in women. As noted on the initiative’s website.
In the mid-1990s, over 160,000 women participated in the WHI study, with more than 40,000 still involved.
Late Thursday, HHS decided to renew support for its long-standing research program. HHS Secretary Robert F. Kennedy Jr. labeled claims about withdrawing funding for the initiative as “fake news.”
“We have not completed this study. NIH Director Dr. Jay Bhatacharya has utilized it in his own research. We all acknowledge that this project is crucial for women’s health,” he stated on x.
An HHS spokesperson confirmed to The Hill that the agency is striving to fully reinstate funding for WHI and its “critical research activities.”
“NIH remains profoundly dedicated to promoting public health through rigorous, gold-standard research and is taking swift measures to guarantee the ongoing progress of these studies,” the spokesperson conveyed to The Hill.
